Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

538 ARTÍCULOS , VIENDO DEL 271 AL 285

Falls in Parkinson's disease: A complex and evolving picture

Fasano A, Canning CG, Hausdorff JM, Lord S, Rochester L.

Mov Disord. 2017 Nov;32(11):1524-1536. doi: 10.1002/mds.27195. Epub 2017 Oct 25.

Cognitive and Neuropsychiatric Features of Early Parkinson's Disease

Getz SJ, Levin B.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):769-785. doi: 10.1093/arclin/acx091.

Structural abnormality of substantia nigra induced by methamphetamine abuse

Rumpf JJ, Albers J, Fricke C, Mueller W, Classen J.

Mov Disord. 2017 Dec;32(12):1784-1788. doi: 10.1002/mds.27205. Epub 2017 Oct 30.

Cognitive impairment in progressive supranuclear palsy is associated with tau burden

Koga S, Parks A, Kasanuki K, Sanchez-Contreras M, Baker MC, Josephs KA, Ahlskog JE, Uitti RJ, Graff-Radford N, van Gerpen JA, Wszolek ZK, Rademakers R, Dickson DW.

Mov Disord. 2017 Dec;32(12):1772-1779. doi: 10.1002/mds.27198. Epub 2017 Oct 30.

Current trends in etiology, prognosis and therapeutic aspects of Parkinson's disease: a review

Jagadeesan AJ, Murugesan R, Vimala Devi S, Meera M, Madhumala G, Vishwanathan Padmaja M, Ramesh A, Banerjee A, Sushmitha S, Khokhlov AN, Marotta F, Pathak S.

Acta Biomed. 2017 Oct 23;88(3):249-262. doi: 10.23750/abm.v88i3.6063.

Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature

Schneider SA, Alcalay RN.

Mov Disord. 2017 Nov;32(11):1504-1523. doi: 10.1002/mds.27193.

Early versus Late Application of Subthalamic deep brain Stimulation to Parkinson's disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study

Jiang L, Poon WS, Moro E, Xian W, Yang C, Zhu XL, Gu J, Cai X, Liu J, Mok V, Liu Y, Xu S, Guo Q, Chen W, Chen L.

BMJ Open. 2017 Nov 16;7(11):e018610. doi: 10.1136/bmjopen-2017-018610.

Rare case of atypical parkinsonism: why family history is important

Malek N, Jampana R, Grosset DG.

Scott Med J. 2017 Nov;62(4):159-162. doi: 10.1177/0036933017727966. Epub 2017 Dec 1.

Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease

Helley MP, Pinnell J, Sportelli C, Tieu K.

Front Genet. 2017 Nov 17;8:177. doi: 10.3389/fgene.2017.00177. eCollection 2017.

Autophagy impairment in Parkinson's disease

Karabiyik C, Lee MJ, Rubinsztein DC.

Essays Biochem. 2017 Dec 12;61(6):711-720. doi: 10.1042/EBC20170023. Print 2017 Dec 12.

microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches

Leggio L, Vivarelli S, L'Episcopo F, Tirolo C, Caniglia S, Testa N, Marchetti B, Iraci N.

Int J Mol Sci. 2017 Dec 13;18(12):2698. doi: 10.3390/ijms18122698.

Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomal iron imaging in Parkinson's disease)

Schwarz ST, Xing Y, Naidu S, Birchall J, Skelly R, Perkins A, Evans J, Sare G, Martin-Bastida A, Bajaj N, Gowland P, Piccini P, Auer DP.

BMJ Open. 2017 Dec 14;7(12):e016904. doi: 10.1136/bmjopen-2017-016904.

Kufor-Rakeb Syndrome Due to a Novel ATP13A2 Mutation in 2 Chinese-American Brothers

Noch E, Henchcliffe C, Hellmers N, Chu ML, Pappas J, Moran E, Alcaraz W, Sarva H.

Mov Disord Clin Pract. 2017 Dec 21;5(1):92-95. doi: 10.1002/mdc3.12567. eCollection 2018 Jan-Feb.

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?

Faustini G, Bono F, Valerio A, Pizzi M, Spano P, Bellucci A.

Genes (Basel). 2017 Dec 8;8(12):377. doi: 10.3390/genes8120377.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias